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LETTER TO THE EDITOR
HUMAN INFECTION WITH AVIAN INFLUENZA A (H7N9) VIRUS
Shanghai, February 24th, 2014
Dear Editor,
On March 31st, 2013, the National Health and Family Planning 
Commission (NHFPC) of China announced that three fatal cases of 
rapidly progressive pneumonia, respiratory failure and acute respiratory 
distress syndrome (ARDS) were confirmed to be infected with a novel 
reassortant avian-origin influenza A (H7N9) virus9. As of February 18th, 
2014, a total of 347 laboratory-confirmed cases and 109 deaths had been 
reported in mainland China7. The novel avian influenza virus has caused 
global concern as a potential pandemic threat.
According to recent studies, the elderly have increased risk for 
H7N9 virus infection2,3. Furthermore, patients with underlying diseases 
are significantly associated with the infection1-3. It is reported that the 
median age of 111 patients with H7N9 virus infection was 61 and 42.3% 
of them were 65 years of age or older3. A total of 61.3% of the patients 
had one or more underlying medical conditions, such as hypertension, 
diabetes, coronary heart disease, chronic obstructive pulmonary disease 
(COPD) and so on3.
Human infection with H7N9 virus has been reported sporadically and 
is mainly associated with exposures to poultry1,4. However, no history 
of recent close contact with poultry was found in some cases2,8. Indeed, 
H7N9 virus had been detected among live poultry at local markets in 
some areas of China8,11. Therefore, the most likely source of H7N9 virus 
in these cases seems to be from the environments contaminated with 
the novel avian influenza virus. Epidemiologically, the elderly patients 
predominate in the H7N9 avian influenza outbreak, for the reason that 
retirees have more opportunities to shop in the live animal markets and 
are, therefore, more likely to be exposed to the environments that are 
contaminated with H7N9 virus3.
The clinical features of H7N9 virus infection are broadly similar 
to those of H5N1 virus infection3,8. The laboratory findings including 
leukopenia, lymphocytopenia, thrombocytopenia and increased levels 
of aspartate aminotransferase (AST), lactate dehydrogenase (LDH), 
creatine kinase (CK) and C-reactive protein (CRP) are also commonly 
seen in patients with H7N9 virus infection3,8. Furthermore, the disease 
is characterized by bilateral ground-glass opacities and consolidation3,8, 
as seen in Fig. 1.
Human infection with H7N9 virus shows a case-fatality rate of 
31% (109/347), which is not as high as that of H5N1 virus infection 
(59%)6. The clinical outcome, on the other hand, is inconsistent with 
that of previous reports on avian influenza A (H7) virus infection, 
which is usually associated with poultry outbreaks, but causes mild 
or moderate illness in humans4. It is estimated that the fatality risk 
is 36% (95% CI 26-45) on admission to hospital for H7N9 virus 
infection10. Increasing age along with a history of smoking, chronic lung 
disease, immunosuppression, chronic drug use and delayed antiviral 
treatment are considered as risk factors which might contribute to the 
fatal outcome5. According to statistics, the median time from onset of 
symptoms to initiation of antiviral therapy is 7.4 and 4.6 days in the 
fatal and non-fatal cases, respectively5. Importantly, the relatively good 
clinical outcome may be attributed to early diagnosis and antiviral 
treatment, which are the most effective strategies for managing H7N9 
virus infection.
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Fig. 1 - Computed tomography (CT) scan of the chest in a 74-year-old female infected with 
avian influenza A (H7N9) virus showing a mixed pattern of ground-glass opacities and 
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